Recombinant tumor necrosis factor increases pulmonary vascular permeability independent of neutrophilsHORVATH, C. J; FERRO, T. J; JESMOK, G et al.Proceedings of the National Academy of Sciences of the United States of America. 1988, Vol 85, Num 23, pp 9219-9223, issn 0027-8424Article

Immunoassays for human tumour necrosis factors alpha and betaMEAGER, A; LEUNG, H; WOOLLEY, J et al.Developments in biological standardization. 1988, Vol 69, issn 0301-5149, 153Conference Paper

A Distinct Role for Transient Receptor Potential Ankyrin 1, in Addition to Transient Receptor Potential Vanilloid 1, in Tumor Necrosis Factor α―Induced Inflammatory Hyperalgesia and Freund's Complete Adjuvant―Induced MonarthritisFERNANDES, Elizabeth S; RUSSELL, Fiona A; BEVAN, Stuart et al.Arthritis and rheumatism. 2011, Vol 63, Num 3, pp 819-829, issn 0004-3591, 11 p.Article

The Cytomegaloviral Protein pUL138 Acts as Potentiator of Tumor Necrosis Factor (TNF) Receptor 1 Surface Density To Enhance ULb'-Encoded Modulation of TNF-α SignalingVU THUY KHANH LE; TRILLING, Mirko; HENGEL, Hartmut et al.Journal of virology. 2011, Vol 85, Num 24, pp 13260-13270, issn 0022-538X, 11 p.Article

Tumor necrosis factor (TNF)-α-induced interleukin-8 in human blood cultures discriminates neutralization by the p55 and p75 TNF soluble receptorsFRISHMAN, Jordan I; EDWARDS, Carl K; SONNENBERG, Michael G et al.The Journal of infectious diseases. 2000, Vol 182, Num 6, pp 1722-1730, issn 0022-1899Article

Crystallization of human tumour necrosis factorWALKER, N; MARCINOWSKI, S; HILLEN, H et al.Journal of crystal growth. 1990, Vol 100, Num 1-2, pp 168-170, issn 0022-0248, 3 p.Article

Release of Soluble Tumor Necrosis Factor Receptor 1 from Corneal Epithelium by TNF-α-Converting Enzyme-Dependent Ectodomain SheddingSAKIMOTO, Tohru; YAMADA, Ai; SAWA, Mitsuru et al.Investigative ophthalmology & visual science. 2009, Vol 50, Num 10, pp 4618-4621, issn 0146-0404, 4 p.Article

Impact of postoperative unwashed shed blood retrieved after total knee arthroplasty on endotoxin-stimulated tumor necrosis factor α release in vitroMUNOZ, Manuel; MUNOZ, Encarnacion; NAVAJAS, Ana et al.Anesthesiology (Philadelphia). 2006, Vol 104, Num 2, pp 267-272, issn 0003-3022, 6 p.Article

Anti-TNF-α therapy for sight threatening uveititisLINDSTEDT, E. W; BAARSMA, G. S; KUIJPERS, R. W. A. M et al.British journal of ophthalmology. 2005, Vol 89, Num 5, pp 533-536, issn 0007-1161, 4 p.Article

Tumor necrosis factor-alpha induced enhancement of cryosurgeryGOEL, Raghav; PACIOTTI, Guilio F; BISCHOF, John C et al.Progress in biomedical optics and imaging. 2008, pp 68420R.1-68420R.14, issn 1605-7422, isbn 978-0-8194-7017-1, 1VolConference Paper

Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journeyAGGARWAL, Bharat B; GUPTA, Subash C; JI HYE KIM et al.Blood. 2012, Vol 119, Num 3, pp 651-665, issn 0006-4971, 15 p.Article

Non-TNF-Biologika in der Therapie : Was kommt nach TNF-Blockern im klinischen Alltag ? = Non-TNF biologicals in therapy : What comes after TNF-blockers in clinical routine ?WOLLENHAUPT, J; BURMESTER, G.-R.Zeitschrift für Rheumatologie (Print). 2010, Vol 69, Num 7, pp 579-580, issn 0340-1855, 2 p.Article

Regulation of the pathophysiology of tumor necrosis factorDEFORGE, L. E; NGUYEN, D. T; KUNKEL, S. L et al.The Journal of laboratory and clinical medicine. 1990, Vol 116, Num 4, pp 429-438, issn 0022-2143Article

Refractory ulcers: The role of tumor necrosis factor—aWEINSTEIN, David A; KIRSNER, Robert S.Journal of the American Academy of Dermatology. 2010, Vol 63, Num 1, pp 146-154, issn 0190-9622, 9 p.Article

Overexpression of tumor necrosis factor causes bilateral sacroiliitisREDLICH, Kurt; GÖRTZ, Birgit; HAYER, Silvia et al.Arthritis and rheumatism. 2004, Vol 50, Num 3, pp 1001-1005, issn 0004-3591, 5 p.Article

The utility of tumour necrosis factor blockade in orphan diseasesKEYSTONE, E. C.Annals of the rheumatic diseases. 2004, Vol 63, pp ii79-ii83, issn 0003-4967, SUP2Article

Tumor necrosis factor-induced endothelial tissue factor is associated with subendothelial matrix vesicles but is not expressed on the apical surfaceRYAN, J; BRETT, J; TIJBURG, P et al.Blood. 1992, Vol 80, Num 4, pp 966-974, issn 0006-4971Article

Tumor necrosis factor and septic shockBAUD, L; CADRANEL, J; OFFENSTADT, G et al.Critical care medicine. 1990, Vol 18, Num 3, pp 349-350, issn 0090-3493Article

Cachectin/tumour necrosis factor-α in the circulation of patients with rheumatic diseaseMAURY, C. P. J; TEPPO, A.-M.International journal of tissue reactions. 1989, Vol 11, Num 4, pp 189-193, issn 0250-0868, 5 p.Article

TNF-α Represses β-Klotho Expression and Impairs FGF21 Action in Adipose Cells: Involvement of JNK1 in the FGF21 PathwayDIAZ-DELFIN, Julieta; HONDARES, Elayne; IGLESIAS, Roser et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 9, pp 4238-4245, issn 0013-7227, 8 p.Article

The Controversial Role of Tumor Necrosis Factor a in Fibrotic DiseasesDISTLER, Jörg H. W; SCHETT, Georg; GAY, Steffen et al.Arthritis and rheumatism. 2008, Vol 58, Num 8, pp 2228-2235, issn 0004-3591, 8 p.Article

Differentiation-inducing and cytotoxic effects of tumor necrosis factor and interferon-gamma in myeloblastic ML-1 cellsCRAIG, R. W; BUCHAN, H. L.Journal of cellular physiology. 1989, Vol 141, Num 1, pp 46-52, issn 0021-9541, 7 p.Article

Anti-tumour necrosis factor agents and lipid profile : a class effect?GARCES, S. P; PARREIRA SANTOS, M. J; VINAGRE, F. M. R et al.Annals of the rheumatic diseases. 2008, Vol 67, Num 6, pp 895-896, issn 0003-4967, 2 p.Article

Tumour necrosis factor inhibitorsNASH, Peter T; FLORIN, Timothy H. J.Medical journal of Australia. 2005, Vol 183, Num 4, pp 205-208, issn 0025-729X, 4 p.Article

Dysregulated expression of tumor necrosis factor in chronic fatigue syndrome : interrelations with cellular sources and patterns of soluble immune mediator expressio nPATARCA, R; KLIMAS, N. G; LUGTENDORF, S et al.Clinical infectious diseases. 1994, Vol 18, pp S147-S153, issn 1058-4838, SUP1Conference Paper